HCPCS Level IIdrugActive
J9282
Mitomycin intravesical inst
BETOS: O1D
Effective: 2026-01-01
Description
Mitomycin, intravesical instillation, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Zusduri
Manufacturer
UroGen Pharma
HCPCS Dosage
1 MG
Billing Units
40.0000
1
NDC Products
opps
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.